NEW YORK (GenomeWeb News) — Oxford Nanopore Technologies has raised £35 million ($59 million) from existing and new investors, bringing its total funding since its founding in 2005 to £180 million ($302 million).

The new funding, through a private placement of ordinary shares, comes from investors in the UK, the US, and mainland Europe. The CF Woodford Equity Income Fund, which is managed by Woodford Investment Management, is one of the new investors.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The London School of Economics' Daniele Fanelli argues at the Proceedings of the National Academy of Sciences that the reproducibility crisis in science isn't as dire as some say.

A team of researchers in Portugal has examined the genomic basis for racing pigeons' athleticism and navigational skills, finding it's likely polygenic.

Wired reports that diagnostic firms continue to seek, post-Theranos, the ability to diagnose diseases from small amounts of blood.

In Science this week: analysis of DNA from ancient North Africans, and more.

Sponsored by
Thermo Fisher Scientific

In this webinar, the first in the “New Frontiers in Liquid Biopsy Research” series, Bea Bellosillo, head of pathology at the Hospital del Mar, will discuss her experience evaluating an early-access lung cancer panel that detects copy number variants and fusions.